Rock Springs Capital Management LP Incyte Corp Transaction History

Rock Springs Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $22.8 Million - $30.2 Million	-300,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $4.25 Million - $5.48 Million	50,000 Added 20.0%	300,000 $26.9 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $4.55 Million - $5.96 Million	-62,300 Reduced 19.95%	250,000 $21.8 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $146,188 - $202,791	2,300 Added 0.74%	312,300 $26.9 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $2.46 Million - $2.94 Million	-42,100 Reduced 11.96%	310,000 $19.7 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $3.46 Million - $4.16 Million	56,100 Added 18.95%	352,100 $24.3 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $6.91 Million - $9.53 Million	113,500 Added 62.19%	296,000 $19.8 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $888,820 - $1.11 Million	9,500 Added 5.49%	182,500 $17.3 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $18.9 Million - $23.9 Million	173,000	173,000 $20.2 Million

645

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.